Alignment Healthcare Revenue 2020-2025 | ALHC
Alignment Healthcare revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Alignment Healthcare Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $2,704 |
| 2023 | $1,824 |
| 2022 | $1,434 |
| 2021 | $1,168 |
| 2020 | $959 |
| 2019 | $757 |
| Alignment Healthcare Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $927 |
| 2024-12-31 | $701 |
| 2024-09-30 | $692 |
| 2024-06-30 | $681 |
| 2024-03-31 | $629 |
| 2023-12-31 | $465 |
| 2023-09-30 | $457 |
| 2023-06-30 | $462 |
| 2023-03-31 | $439 |
| 2022-12-31 | $362 |
| 2022-09-30 | $360 |
| 2022-06-30 | $366 |
| 2022-03-31 | $346 |
| 2021-12-31 | $298 |
| 2021-09-30 | $293 |
| 2021-06-30 | $309 |
| 2021-03-31 | $267 |
| 2020-12-31 | $242 |
| 2020-09-30 | $248 |
| 2020-06-30 | $244 |
| 2020-03-31 | $225 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.602B | $2.704B |
| Alignment Healthcare Inc. is a consumer-centric platform delivering customized health care in the United States to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. Alignment Healthcare Inc. is based in ORANGE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Labcorp Holdings (LH) | United States | $20.694B | 16.78 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.295B | 88.37 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |